ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,490, issued on Dec. 23, was assigned to Northeastern University (Boston).

"Method of treating Gram-negative bacterial infection with isolated darobactin compounds" was invented by Kim Lewis (Newton, Mass.), Yu Imai (Hyoto, Japan), Quentin Favre-Godal (Geneva), Akira Iinishi (Newton, Mass.) and Kirsten Meyer (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present invention relate to a novel compound of Formula (I)or stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, for use in treatment of infection caused by Gram-negative bacteria."

The patent was filed on Nov. 17, 2022, under Application No. 18/056,...